Optimal two-stage designs for phase ii clinical trials with differentiation of complete and partial responses (Q4550632): Difference between revisions
From MaRDI portal
Set profile property. |
ReferenceBot (talk | contribs) Changed an Item |
||
| (One intermediate revision by one other user not shown) | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1080/03610920008832524 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W1967011174 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: One-Sample Multiple Testing Procedure for Phase II Clinical Trials / rank | |||
Normal rank | |||
Latest revision as of 16:08, 4 June 2024
scientific article; zbMATH DE number 1788559
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal two-stage designs for phase ii clinical trials with differentiation of complete and partial responses |
scientific article; zbMATH DE number 1788559 |
Statements
Optimal two-stage designs for phase ii clinical trials with differentiation of complete and partial responses (English)
0 references
10 December 2003
0 references
cancer clinical trials
0 references
phase II trials
0 references
optimization
0 references
trinomial distribution
0 references
drug screening
0 references
tables
0 references
